目的:探讨缬沙坦联合贝那普利治疗糖尿病肾病的临床疗效.方法:选取2010年5月~2014年5月南口铁路医院收治的80例糖尿病肾病患者,随机分为观察组、对照组,对照组对病人采取缬沙坦治疗,观察组对病人采取缬沙坦联合贝那普利治疗,对观察组与对照组病人之间的相关治疗效果给予分析研究.结果:观察组临床治疗总体有效率明要比对照组高(P<0.05);观察组的肾脏功能改善情况要比对照组高(P<0.05);观察组不良反应发生率要比对照组低(P<0.05).结论:缬沙坦联合贝那普利在糖尿病肾病临床治疗中的应用,阻断了不良因素对患者肾脏的影响,提高了血压的控制率,延缓患者病情的发展,保障患者的生命安全.%Objective: To investigate the clinical efficacy of valsartan combined with benazepril in the treatment of diabetic nephropathy.Methods:80 cases of patients with diabetic nephropathy in our hospital from January 2011 to December 2013,Divided into the control group and the observation group,the control group patients were treated with valsartan,the observed group were treated with Valsartan combined and benazepril,Observed the treatment effect between the control group wth the observation group.Results:The clinical observation group was higher,There was a significant difference (P < 0.05),the iImprovement of renal function,the observation group was better than the control group (P < 0.05),The incidence of adverse reactions,the observation group was than lower the control group (P < 0.05).Conclusion:Clinical application of valsartan combined benazepril in the treatment of diabetic nephropathy,blocking the impact of adverse factors on kidney patients,improved blood pressure control rate,delay the development of the patient's condition,and ensure the life safety of patients.
展开▼
